Skip to content
ARVO 2025 presentation: Thioredoxin system and HIF1a pathway activation by oxidative stress in human iPSC-RPE cells

ARVO 2025 presentation: Thioredoxin system and HIF1a pathway activation by oxidative stress in human iPSC-RPE cells

In vitro: Retinal pigment epithelium (RPE) cells exhibit a high susceptibility to reactive oxygen species (ROS) due to their elevated metabolic activity. The accumulation of ROS is a critical factor contributing to the pathogenesis of both dry and wet forms of age-related macular degeneration (AMD). The thioredoxin (TRX) system represents one of the two primary thiol-dependent antioxidant defense mechanisms in mammalian cells. The objective of this study was to investigate the concentration-dependent activation and response of the TRX system to ROS induced by RPE specific exogenous oxidative agent, sodium iodate (NaIO3).

Learn more Arrow right
ARVO 2025

ARVO 2025

The ARVO 2025 Annual Meeting is just around the corner! Our teams from Finland, Lithuania, and France are getting ready for the trip to Salt Lake City.

Learn more Arrow right
Improving corneal permeability of dexamethasone using penetration enhancing agents: first step towards achieving topical drug delivery to the retina​​

Improving corneal permeability of dexamethasone using penetration enhancing agents: first step towards achieving topical drug delivery to the retina​​

To date, ocular injections and implants are the most effective methods for drug delivery to the back of the eye. However, invasive delivery methods also are costly and risky due to possible complications. In this paper, a novel proprietary polyacetylene polymer and two cell penetrating peptides are compared for topical drug delivery to treat retinal diseases.

Learn more Arrow right
AAALAC accredited company

All our facilities are AAALAC accredited, reflecting our commitment to the highest standards of animal care in research.